Because this is a powerful compound that influences core metabolic pathways, its use requires a thoughtful approach
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
Sanai, F
Gen Comp Endocrinol 175, 2733, doi: 10.1016/j.ygcen.2011.11.025 (2012)
SOURCE: Annals of Internal Medicine , March 31, 2025 Copyright 2025 HealthDay
The FDA recommends a maximum dose of 2.4 mg of semaglutide once weekly for weight loss